Aethlon Medical, Inc. (OTCBB: AEMD) will be giving a presentation at the French Biotech Tour being held in La Jolla, CA at The Salk Institute.
The company’s Chief Science Officer, Richard H. Tullis, Ph.D., will host their presentation on March 15, 2010. The event will showcase some of the most innovative new technologies developed by Californian and French biotech companies to tackle infectious diseases and improve the patient’s life quality.
Xplosive Stocks, an online financial publication, provides investors timely stock market information.
Sign Up Today for our Free Stock Newsletter
Aethlon Medical, Inc. creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our lead product, the Hemopurifier® is the first-in-class medical device to selectively capture circulating viruses and immunosuppressive proteins prior to cell and organ infection.
Sign up for the free Xplosive Stocks newsletter. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by Xplosive Stocks can sign up for free by visiting our website.
About Us
Xplosive Stock is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We focus on Xplosive Stocks and track small cap companies that are on the brink of a financial breakout. To feature a company on our website please contact us at the email listed below.
Please click here to read the full disclaimer.
